Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.800
+0.039 (5.12%)
At close: Dec 20, 2024, 4:00 PM
0.839
+0.039 (4.86%)
After-hours: Dec 20, 2024, 7:57 PM EST
Trinity Biotech Revenue
Trinity Biotech had revenue of $15.15M in the quarter ending September 30, 2024, with 3.24% growth. This brings the company's revenue in the last twelve months to $59.13M, down -17.18% year-over-year. In the year 2023, Trinity Biotech had annual revenue of $56.83M, down -9.10%.
Revenue (ttm)
$59.13M
Revenue Growth
-17.18%
P/S Ratio
0.12
Revenue / Employee
$155,595
Employees
380
Market Cap
7.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
Dec 31, 2020 | 101.98M | 11.55M | 12.77% |
Dec 31, 2019 | 90.44M | -6.60M | -6.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cutera | 155.21M |
Star Equity Holdings | 50.38M |
XWELL | 33.83M |
T2 Biosystems | 7.68M |
Elevai Labs | 2.45M |
Soligenix | 364.18K |
Cyclerion Therapeutics | 194.00K |
TRIB News
- 3 days ago - Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV - GlobeNewsWire
- 5 weeks ago - Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Trinity Biotech Announces Q3 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Trinity Biotech to Announce Q3 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Trinity Biotech Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform - GlobeNewsWire
- 2 months ago - Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology - GlobeNewsWire